発酵技術、微生物機能、合成を利用し、様々な製品を生み出しています。
Commercial
Compound name | CAS | Specification | Structure |
---|---|---|---|
Daunorubicin Hydrochloride | 23541-50-6 | USP, JP, CP, In-house | |
Doxorubicin Hydrochloride | 25316-40-9 | USP, JP, EP, CP, In-house | |
Epirubicin Hydrochloride | 56390-09-1 | JP, EP, In-house | |
Pirarubicin * | 72496-41-4 | JP, In-house | |
Aclarubicin Hydrochloride * | 75443-99-1 | JP, In-house |
Compound name | CAS | Specification | Structure |
---|---|---|---|
Calcitriol | 32222-06-3 | USP, In-house |
Compound name | CAS | Specification | Structure |
---|---|---|---|
cis-5-Hydroxy-L-Pipecolinic acid | 63088-78-8 | In-house |
Compound name | CAS | Specification | Structure |
---|---|---|---|
Rapamycin (Sirolimus) Crude | 53123-88-9 | In-house |
Under development
Compound name | CAS | Structure |
---|---|---|
Everolimus | 159351-69-6 | |
Oxaunomycin | 105615-58-5 | |
Ansamitocin P-3 | 66584-72-3 | |
Maytansinol | 57103-68-1 | |
Mertansine (DM-1) | 139504-50-0 | |
25-Hydroxy vitamin D3 | 63283-36-3 | |
25-Hydroxycholesterol | 2140-46-7 | |
Calicheamicin γ1 | 108212-75-5 |
発酵製品
発酵+合成の製品
微生物変換製品
* 原薬と製剤